GlassScriptPhysician profile
Thomas T Tigges
NPI 1558360065
$2,255.82
in general payments reported to CMS, 2019-2025
24 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $605 · 2021: $416 · 2022: $86.82 · 2023: $292 · 2024: $614 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,148.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $260.56 | 2019 | |
| Intuitive Surgical, INC. | $256.31 | 2019-2024 | |
| Conmed Corporation | $199.30 | 2024 | Airseal |
| Integra Lifesciences Corporation | $195.15 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Teleflex LLC | $172.69 | 2021-2024 | Arrow |
| Baxter Healthcare | $138.62 | 2021 | |
| Haemonetics Corporation | $117.00 | 2023 | Teg6s Hemostasis System |
| Stryker Corporation | $113.32 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $109.21 | 2021-2025 | Gattex |
| Medtronic, INC. | $101.29 | 2021-2023 | Progrip |
| Acera Surgical, INC. | $98.58 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $91.85 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Acell, INC. | $78.99 | 2019 | |
| Tela Bio, INC. | $62.93 | 2022-2024 | Ovitex 2s |
| Abbvie INC. | $50.72 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $43.34 | 2023-2024 | Collagenase Santyl |
| Convatec INC. | $32.13 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $24.71 | 2025 | |
| Becton, Dickinson and Company | $22.73 | 2025 | Phasix Mesh |
| Aroa Biosurgery Incorporated | $21.66 | 2024 | |
| Covidien LP | $17.85 | 2019 | |
| Octapharma USA, INC. | $17.19 | 2025 | Fibryga |
| Innocoll Pharmaceuticals Limited | $15.34 | 2021 | |
| Biocomposites INC | $14.35 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Tigges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.